메뉴 건너뛰기




Volumn 74, Issue SUPPL. XXVII, 1996, Pages

Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N

Author keywords

AQ4N; Bioreductive drug; DACA; DMXAA; Hypoxia; Topoisomerase inhibitor

Indexed keywords

1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; AMINE OXIDE; ANTINEOPLASTIC AGENT; N (2 DIMETHYLAMINOETHYL) 4 ACRIDINECARBOXAMIDE; NITRACRINE; PRODRUG; 1,4 BIS[[2 (DIMETHYLAMINO N OXIDE)ETHYL]AMINO] 5,8 DIHYDROXYANTHRAQUINONE; 5,6 DIMETHYLXANTHENONEACETIC ACID; 5,6-DIMETHYLXANTHENONEACETIC ACID; ACRIDINE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; C 684; DRUG DERIVATIVE; INTERCALATING AGENT; XANTHENE DERIVATIVE; XANTHONE DERIVATIVE;

EID: 0029935930     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (63)

References (16)
  • 1
    • 0023251054 scopus 로고
    • Potential antitumor agents. 50. In vivo solid tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide
    • ATWELL GJ, REWCASTLE GW, BAGULEY GW AND DENNY WA. (1987). Potential antitumor agents. 50. In vivo solid tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. J. Med. Chem., 30, 664-669.
    • (1987) J. Med. Chem. , vol.30 , pp. 664-669
    • Atwell, G.J.1    Rewcastle, G.W.2    Baguley, G.W.3    Denny, W.A.4
  • 2
    • 0028234390 scopus 로고
    • Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid
    • CLIFFE S, TAYLOR ML, RUTLAND M, BAGULEY B, HILL RP AND WILSON WR. (1994). Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid. Int. J. Radiat. Oncol. Biol. Phys., 29, 373-377.
    • (1994) Int. J. Radiat. Oncol. Biol. Phys. , vol.29 , pp. 373-377
    • Cliffe, S.1    Taylor, M.L.2    Rutland, M.3    Baguley, B.4    Hill, R.P.5    Wilson, W.R.6
  • 4
    • 0028841105 scopus 로고
    • Interactions of acridine antitumour agents with DNA: Binding energies and groove preferences
    • CRENSHAW JM, GRAVES DE AND DENNY WA. (1995). Interactions of acridine antitumour agents with DNA: binding energies and groove preferences. Biochemistry, 34, 13862-13867.
    • (1995) Biochemistry , vol.34 , pp. 13862-13867
    • Crenshaw, J.M.1    Graves, D.E.2    Denny, W.A.3
  • 5
    • 0022535929 scopus 로고
    • Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumour cells
    • DENNY WA AND WILSON WR. (1986). Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumour cells. J. Med. Chem., 29, 879-887.
    • (1986) J. Med. Chem. , vol.29 , pp. 879-887
    • Denny, W.A.1    Wilson, W.R.2
  • 6
    • 0024589187 scopus 로고
    • Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro
    • FINLAY GJ AND BAGULEY BC. (1989). Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro. Eur. J. Cancer Clin. Oncol., 25, 271-277.
    • (1989) Eur. J. Cancer Clin. Oncol. , vol.25 , pp. 271-277
    • Finlay, G.J.1    Baguley, B.C.2
  • 7
    • 0027447244 scopus 로고
    • In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced senstivity to multidrug resistance
    • FINLAY GJ, MARSHALL E, MATTHEWS JHL, PAUL KD AND BAGULEY BC. (1993). In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced senstivity to multidrug resistance. Cancer Chemother. Pharmacol., 31, 401-406.
    • (1993) Cancer Chemother. Pharmacol. , vol.31 , pp. 401-406
    • Finlay, G.J.1    Marshall, E.2    Matthews, J.H.L.3    Paul, K.D.4    Baguley, B.C.5
  • 8
    • 0029952167 scopus 로고    scopus 로고
    • Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracine N-oxide
    • in press
    • LEE HH, WILSON WR, FERRY DM, VAN ZIJL P, PULLEN SM AND DENNY WA. (1996). Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracine N-oxide. J. Med. Chem. (in press).
    • (1996) J. Med. Chem.
    • Lee, H.H.1    Wilson, W.R.2    Ferry, D.M.3    Van Zijl, P.4    Pullen, S.M.5    Denny, W.A.6
  • 9
    • 0029054994 scopus 로고
    • AQ4N: An alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo
    • MCKEOWN SR, HEJMADI MV, MCINTYRE IA, MCALEER JJA AND PATTERSON LH. (1995). AQ4N: An alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo. Br. J. Cancer, 72, 76-81.
    • (1995) Br. J. Cancer , vol.72 , pp. 76-81
    • Mckeown, S.R.1    Hejmadi, M.V.2    Mcintyre, I.A.3    Mcaleer, J.J.A.4    Patterson, L.H.5
  • 10
    • 0028952450 scopus 로고
    • N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)-butanamide (NNB, NSC 639862), a bis-bioreductive agent with marked selective toxicity towards hypoxic cells
    • MOSELEN J, HAY M, DENNY WA AND WILSON WR. (1995). N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)-butanamide (NNB, NSC 639862), a bis-bioreductive agent with marked selective toxicity towards hypoxic cells. Cancer Res., 55, 574-580.
    • (1995) Cancer Res. , vol.55 , pp. 574-580
    • Moselen, J.1    Hay, M.2    Denny, W.A.3    Wilson, W.R.4
  • 11
    • 0028916689 scopus 로고
    • Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862)
    • PALMER BD, VAN ZIJL P, DENNY WA AND WILSON WR. (1995). Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862). J. Med. Chem., 38, 1229-1241.
    • (1995) J. Med. Chem. , vol.38 , pp. 1229-1241
    • Palmer, B.D.1    Van Zijl, P.2    Denny, W.A.3    Wilson, W.R.4
  • 12
    • 0027220811 scopus 로고
    • Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: A new class of bioreductive agent
    • PATTERSON LH. (1993). Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent. Cancer Metastasis Rev., 12, 119-134.
    • (1993) Cancer Metastasis Rev. , vol.12 , pp. 119-134
    • Patterson, L.H.1
  • 14
    • 0021054290 scopus 로고
    • Hypersensitivity to cell killing and mutation induction by chemical carcinogens in an excision repair-deficient mutant of CHO cells
    • THOMPSON LH, SALAZAR EP, BROOKMAN KW AND HOY CA. (1983). Hypersensitivity to cell killing and mutation induction by chemical carcinogens in an excision repair-deficient mutant of CHO cells. Mutation Res., 112, 329-344.
    • (1983) Mutation Res. , vol.112 , pp. 329-344
    • Thompson, L.H.1    Salazar, E.P.2    Brookman, K.W.3    Hoy, C.A.4
  • 15
    • 0026520313 scopus 로고
    • Bis-bioreductive agents as hypoxia-selective cytotoxins: Nitracrine N-oxide
    • WILSON, WR, VAN ZIJL, P & DENNY. WA (1992). Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide. Int. J. Radiat. Oncol. Biol. Phys., 22, 693-696.
    • (1992) Int. J. Radiat. Oncol. Biol. Phys. , vol.22 , pp. 693-696
    • Wilson, W.R.1    Van Zijl, P.2    Denny, W.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.